Australia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise

BCAL Diagnostics

Mon 04:32

** Shares of molecular diagnostics firm Genetic Signatures GSS.AX rise 5% to A$0.084 
** GSS Suspects BCAL Diagnostics BDX.AX, its largest shareholder, intends to pursue a merger with co, given respective cash positions of BCAL and GSS
** Calls for BCAL to clarify such intentions
** Stock down 66.4% YTD, including moves in current session

(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((Jasmeenaraislam.Shaikh@thomsonreuters.com;))